APPLICATION
ANDA075671
TYPE
ANDA
ORIGINAL APPROVAL
2001-07-25
LATEST ACTION
2020-05-19
ROUTE
ORAL
DOSAGE FORM
SUSPENSION
MARKETING STATUS
Prescription
Products
MEGESTROL ACETATEPrescription
MEGESTROL ACETATE 40MG/ML · SUSPENSION · ORAL
Approval history
2020-05-19Labeling · Supplement 23 · standardAP
2013-01-16Labeling · Supplement 16 · standardAP
2004-05-04Labeling · Supplement 11AP
2004-02-23Labeling · Supplement 8AP
2003-08-14Labeling · Supplement 7AP
2002-10-01Manufacturing (CMC) · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.